259 related articles for article (PubMed ID: 21212414)
1. Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity.
Salah Z; Melino G; Aqeilan RI
Cancer Res; 2011 Mar; 71(5):2010-20. PubMed ID: 21212414
[TBL] [Abstract][Full Text] [Related]
2. The ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway.
Salah Z; Itzhaki E; Aqeilan RI
Oncotarget; 2014 Nov; 5(21):10886-900. PubMed ID: 25350971
[TBL] [Abstract][Full Text] [Related]
3. Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability [corrected].
Ho KC; Zhou Z; She YM; Chun A; Cyr TD; Yang X
Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4870-5. PubMed ID: 21383157
[TBL] [Abstract][Full Text] [Related]
4. NEDD4 E3 ligase inhibits the activity of the Hippo pathway by targeting LATS1 for degradation.
Salah Z; Cohen S; Itzhaki E; Aqeilan RI
Cell Cycle; 2013 Dec; 12(24):3817-23. PubMed ID: 24107629
[TBL] [Abstract][Full Text] [Related]
5. WWP1 E3 ligase targets LATS1 for ubiquitin-mediated degradation in breast cancer cells.
Yeung B; Ho KC; Yang X
PLoS One; 2013; 8(4):e61027. PubMed ID: 23573293
[TBL] [Abstract][Full Text] [Related]
6. The E3 ubiquitin ligase Itch regulates tumor suppressor protein RASSF5/NORE1 stability in an acetylation-dependent manner.
Suryaraja R; Anitha M; Anbarasu K; Kumari G; Mahalingam S
Cell Death Dis; 2013 Mar; 4(3):e565. PubMed ID: 23538446
[TBL] [Abstract][Full Text] [Related]
7. DUB3 Deubiquitylating Enzymes Regulate Hippo Pathway Activity by Regulating the Stability of ITCH, LATS and AMOT Proteins.
Nguyen HT; Kugler JM; Cohen SM
PLoS One; 2017; 12(1):e0169587. PubMed ID: 28061504
[TBL] [Abstract][Full Text] [Related]
8. The E3 ubiquitin ligase Itch and Yap1 have antagonistic roles in the regulation of ASPP2 protein stability.
Gao K; An J; Zhang Y; Jin X; Ma J; Peng J; Tang Y; Yu L; Zhang P; Wang C
FEBS Lett; 2015 Jan; 589(1):94-101. PubMed ID: 25436413
[TBL] [Abstract][Full Text] [Related]
9. SPOP promotes ubiquitination and degradation of LATS1 to enhance kidney cancer progression.
Wang L; Lin M; Chu M; Liu Y; Ma J; He Y; Wang ZW
EBioMedicine; 2020 Jun; 56():102795. PubMed ID: 32460168
[TBL] [Abstract][Full Text] [Related]
10. WWP2 drives the progression of gastric cancer by facilitating the ubiquitination and degradation of LATS1 protein.
Zou J; Zhou L; Le Y; Fang Z; Zhong M; Nie F; Wei X; Zhang X; Chen Z; Cai L; Wang H; Xiong J; Fang Z; Xiang X
Cell Commun Signal; 2023 Feb; 21(1):38. PubMed ID: 36803368
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the Hippo signaling pathway by ubiquitin modification.
Kim Y; Jho EH
BMB Rep; 2018 Mar; 51(3):143-150. PubMed ID: 29366444
[TBL] [Abstract][Full Text] [Related]
12. Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1.
Si Y; Ji X; Cao X; Dai X; Xu L; Zhao H; Guo X; Yan H; Zhang H; Zhu C; Zhou Q; Tang M; Xia Z; Li L; Cong YS; Ye S; Liang T; Feng XH; Zhao B
Cancer Res; 2017 Sep; 77(18):4868-4880. PubMed ID: 28754671
[TBL] [Abstract][Full Text] [Related]
13. Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway.
Zhu C; Ji X; Zhang H; Zhou Q; Cao X; Tang M; Si Y; Yan H; Li L; Liang T; Feng XH; Zhao B
J Biol Chem; 2018 Jan; 293(4):1178-1191. PubMed ID: 29183995
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Itch and Nedd4 E3 Ligase Activity and Degradation by LRAD3.
Noyes NC; Hampton B; Migliorini M; Strickland DK
Biochemistry; 2016 Mar; 55(8):1204-13. PubMed ID: 26854353
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase.
Ma B; Chen Y; Chen L; Cheng H; Mu C; Li J; Gao R; Zhou C; Cao L; Liu J; Zhu Y; Chen Q; Wu S
Nat Cell Biol; 2015 Jan; 17(1):95-103. PubMed ID: 25438054
[TBL] [Abstract][Full Text] [Related]
16. Wnt Signaling Promotes Breast Cancer by Blocking ITCH-Mediated Degradation of YAP/TAZ Transcriptional Coactivator WBP2.
Lim SK; Lu SY; Kang SA; Tan HJ; Li Z; Adrian Wee ZN; Guan JS; Reddy Chichili VP; Sivaraman J; Putti T; Thike AA; Tan PH; Sudol M; Virshup DM; Chan SW; Hong W; Lim YP
Cancer Res; 2016 Nov; 76(21):6278-6289. PubMed ID: 27578003
[TBL] [Abstract][Full Text] [Related]
17. S100 Calcium Binding Protein A16 Promotes Cell Proliferation by triggering LATS1 ubiquitin degradation mediated by CUL4A ligase to inhibit Hippo pathway in Glioma development.
Hu Y; Zhang R; Lu S; Zhang W; Wang D; Ge Y; Jiang F; Qin X; Liu Y
Int J Biol Sci; 2023; 19(7):2034-2052. PubMed ID: 37151881
[No Abstract] [Full Text] [Related]
18. Gα
Yagi H; Onoyama I; Asanoma K; Hori E; Yasunaga M; Kodama K; Kijima M; Ohgami T; Kaneki E; Okugawa K; Yahata H; Kato K
FASEB J; 2019 Dec; 33(12):13683-13694. PubMed ID: 31569999
[TBL] [Abstract][Full Text] [Related]
19. Deubiquitinase YOD1: the potent activator of YAP in hepatomegaly and liver cancer.
Kim Y; Jho EH
BMB Rep; 2017 Jun; 50(6):281-282. PubMed ID: 28502290
[TBL] [Abstract][Full Text] [Related]
20. Numb activates the E3 ligase Itch to control Gli1 function through a novel degradation signal.
Di Marcotullio L; Greco A; Mazzà D; Canettieri G; Pietrosanti L; Infante P; Coni S; Moretti M; De Smaele E; Ferretti E; Screpanti I; Gulino A
Oncogene; 2011 Jan; 30(1):65-76. PubMed ID: 20818436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
